Buspirone in Alzheimer’s disease

References

• Cummings JL, Cole G. Alzheimer's disease. PIN/A 287,2335–2338 (2002).
   Google Scholar
• Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J. Public Health 88,1337–1342 (1998).
   PubMed Web of Science ®Google Scholar
• Desai AK, Grossberg GT. Recognition and
   Google Scholar
• ••management of behavioral disturbances in dementia. Primary Care Companion. Clin. Psychiatry3, 93–109 (2001).
   Google Scholar
• Steele C, Rovner B, Chase GA, Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. A117. I Psychiatry147,1049–1051 (1990).
   Google Scholar
• Balestreri L, Grossberg GT. BPSD as a risk factor for nursing home placement. Poster presented at the Annual Symposium of the American Medical Directors Association. San Francisco, CA, USA, March 16–19, 2000.
   Google Scholar
• Ballard C, Boyle A, Bowler C, Lindesay J. Anxiety disorders in dementia sufferers. Int. Ceriati: Ptychiatry 11,987–990 (1996).
   Web of Science ®Google Scholar
• Jost B, Grossberg G. The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study. J. Am. Ceriatr Soc. 44,1078–1081 (1996).
   Google Scholar
• Mega MS, Cummings JL, Fiorello T, Gombein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology 46,130–135 (1996).
   PubMed Web of Science ®Google Scholar
• Ownby RL, Harwood DG, Barker WW, Duara R. Predictors of anxiety in patients with Alzheimer's disease. Depress. Anxiety 11, 38–42 (2000).
   PubMedGoogle Scholar
• Reisberg B, Borenstein J, Salob SP eta]. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J. Clin. Psychiatry 48,9-15 (1987). itFerretti L, McCurry SM, Logsdon R, Gibbons L, Teri L. Anxiety and Alzheimer's disease. I Ceriatr Psychiatry Neural. 14, 52–58 (2001).
   Google Scholar
• Ballard CG, Mohan-Ramalingam NC, Patel A, Graham C. Anxiety disorders in dementia. Irj Ptychol Medll, 108–109 (1994).
   Google Scholar
• Bungener C, Jouvent R, Derousesne C. Affective disturbances in Alzheimer's disease. jAm. Ceriatr Soc. 44,1066–1071 (1996).
   Google Scholar
• Chemerinski E, Petracca G, Manes F et al Prevalence and correlates of anxiety in Alzheimer's disease. Depress. Anxiety7, 166–170 (1998).
   PubMedGoogle Scholar
• Brown TA. The nature of generalized anxiety disorder and pathological worry: current evidence and conceptual models. Can. Psychiatty 42, 817–825 (1997).
   PubMedGoogle Scholar
• Bums A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer's disease. Parts I-IV. Br. Psychiatry (1990).
   Google Scholar
• Aarsland D, Cummings JL, Yenner G, Miller B. Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer's disease. Am. J. Psychiatry 153,243–247 (1996).
   PubMed Web of Science ®Google Scholar
• Swearer JM, Drachman DA, O'Donnell BF, Mitchell AL. Troublesome and disruptive behaviors in dementia: relationships to diagnosis and disease severity. jAm. Cetiatr Soc. 36,784-790 (1988).
   Google Scholar
• Ttherti C, Sabe L, Kuzis G eta]. Prevalence and correlates of the catastrophic reactions in Alzheimer's disease. Neurology 50,546–548 (1998).
   Google Scholar
• Weiner ME, Svetlik D, Risser RC. What depressive symptoms are reported in Alzheimer's patients? Int. J. Ceriatr Psychiatry12,648–652 (1997).
   PubMedGoogle Scholar
• Teri L, Ferretti LE, Gibbons LE etal Behavioral symptoms in Alzheimer's disease: prevalence and comorbidity. Cerontol Med. Li. 54A, M348—M352 (1999).
   Google Scholar
• Mintzer JE, Brawman-Mintzer O. Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach. J. Clin. Ptychiatry57\(Suppl. 7), 55–63 (1996).
   Google Scholar
• Schneider LS. Overview of generalized anxiety disorder in the elder. j Clin. Psychiatry 57\(Suppl. 7), 34–45 (1996).
   Google Scholar
• Finlayson RE, Davis U. Prescription drug dependence in the elderly population: Demographic and clinical features of 100 in-patients. Mayo Clin. Proc. 69,1137-1145 (1994).
   Google Scholar
• Katz J, Winger G. Benzodiazepines: use, abuse and consequences. Phalmacol. Rev 44,151–347 (1992).
   PubMedGoogle Scholar
• Llorente MD, David D, Golden AG eta]. Defining patterns of benzodiazepine use in older adults. J. Cetiatr Psychiatry Neural. 13(3), 150–160 (2000).
   Google Scholar
• Szwabo PA. Substance abuse in older women. Clin. Ceriatr Med 9,197–208 (1993).
   PubMedGoogle Scholar
• Fourrier A, Letenneur L, Dartigues JF, Moore N, Begaud B. Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur. j Clin. Phatmacol. 57(5), 419–425 (2001).
   Google Scholar
• Kirby M, Denihan A, Bruce I, Radic A, Coakley D, Lawlor BA. Benzodiazepine use among the elderly in the community. Int. J. Ceriatr Psychiatry 14(4), 280–284 (1999).
   Google Scholar
• Miller NS, Belkin BM, Gold MS. Alcohol and drug dependence among the elderly: epidemiology, diagnosis and treatment. Compr. Ptychiatry 32(2), 153–165 (1991).
   Google Scholar
• Buck JA. Psychotropic drug practice in nursing homes. jAm. Cetiatr Soc. 36, 409–418 (1988).
   Google Scholar
• Gill SS, Misiaszek BC, Brymer C. Improving prescribing in the elderly: a study in the long-term care setting. Can. J. Clin. Pharmacol 8(2), 78–83 (2001).
   Google Scholar
• Stem RG, Duffelmeyer ME, Zemishlani Z etal The use of benzodiazepines in the management of behavioral symptoms in dementia patients. fiychiatr Clin. N Am. 14,375–384 (1991).
   PubMed Web of Science ®Google Scholar
• Kirven LE, Montero EE Comparison of thioridazine and diazepam in the control of nonpsychotic symptoms associated with senility: double-blind study. J. A117. Cetiatr Soc. 21,546-551 (1973).
   Google Scholar
• Coccaro EF, Kramer E, Zemishlany Z eta]. Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients. Am. J. fiychiatry147, 1640–1656 (1990).
   Google Scholar
• Covington J. Alleviating agitation, apprehension and related symptoms in geriatric patients. South Med. j 68,719–724 (1975).
   PubMed Web of Science ®Google Scholar
• Stotsky B. Multicenter study comparing thioridazine and diazepam and placebo in elderly nonpsychotic patients with emotional and behavioral disorders. Clin. Titer 6,546–559 (1984).
   Google Scholar
• Cevera AA. Psychoactive drug therapy in the senile patient: controlled comparison of thioridazine and diazepam. Psychiatry Digest 15–21 (1974).
   Google Scholar
• Beber CR. Management of behavior in the institutionalized aged. Dis. Nerv. Syst. 26, 591–595 (1965).
   PubMedGoogle Scholar
• Lemos GP, Clement MA, Nickels E. Effects of diazepam suspension in geriatric patients hospitalized for psychiatric illnesses. J. Am. Geriatr. Soc. 13, 355–359 (1965).
   Google Scholar
• Rabins P, Blacker D, Bland W eta]. Treatment of patients with Alzheimer's disease and other dementias of late-life. In: Practice Guidelines for the treatment of psychiatric disorders. American Psychiatric Association, Washington DC, USA, 69–137 (2002).
   Google Scholar
• Starr JM, Whalley U. Drug-induced dementia. Incidence, management and prevention. Drug- Safety 11(5), 10–17 (1994).
   Google Scholar
• Moore AR, O'Keeffe ST Drug-induced cognitive impairment in the elderly. Drugs Aging-15W, 15–28 (1999).
   Google Scholar
• Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Safety21(2), 101–122 (1999).
   PubMed Web of Science ®Google Scholar
• Salzman C, Fisher J, Nobel K et al Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. int. j Geriatric Psychiatry 7,89–93 (1992).
   Web of Science ®Google Scholar
• Lechin F, van der Dijs B, Benaim M. Benzodiazepines: tolerability in elderly patients. Ptychother. Psychosom. 65(4), 171–182 (1996).
   PubMed Web of Science ®Google Scholar
• Schneider LS. Efficacy of treatment for geropsychiatric patients with severe mental illness. Ptychopharmacol Bull. 29(4), 501–524 (1993).
   Google Scholar
• Palmer AM, Stratman GC, Procter AW et al Possible neurotransmitter basis of behavioral changes in Alzheimer's disease. Ann. Neural 23,616–620 (1988).
   PubMed Web of Science ®Google Scholar
• Lanctot KL, Herrmann N, Mazzotta P Role of serotonin in the behavioral and psychological symptoms of dementia. j Neuropsychiatry Clin. Neurosci 13(1), 5–21 (2001).
   Google Scholar
• Siever LJ, Kahn RS, Lawlor BA etal Critical issues in defining the role of serotonin in psychiatric disorders. Pharmacol Rev. 43,509–525 (1991).
   PubMed Web of Science ®Google Scholar
• Dubovksy SL, Thomas M. Serotonergic mechanisms and current and future psychiatric practice. j Clin. Psychiatry 56\(Suppl. 2), 38–48 (1995).
   Google Scholar
• Fuller RW. Role of serotonin in therapy of depression and related disorders. j Clin. fiychiatry52 (Suppl. 5), 52–57 (1991).
   Google Scholar
• Apter JT, Allen LA. Buspirone: future
   Google Scholar
• ••directions. J. Clin. Ptychopharmacol 19 (1), 86–93 (1999).
   Google Scholar
• Krasucki C, Howard R, Mann A. Anxiety
   Google Scholar
• ••and its treatment in the elder. Int. fiychogreriatrics 11, 25–45 (1999).
   Google Scholar
• Ninan PT, Cole JO, Yonkers IKA. Nonbenzodiazepine Anxiolytics. In: Textbook of Psychopharmacology 2nd edition. Shatzberg AF, Nemeroff CB (Eds). American Psychiatric Press Inc., Washington DC, USA, 287–300 (1998).
   Google Scholar
• Hyler SE. Psychotropic drug interactions. Primary Psychiatry9(3), 27–57 (2002).
   Google Scholar
• Barbee JG, McLaulin JB. Anxiety disorders:
   Google Scholar
• •Diagnosis and pharmacotherapy in the elderly. Psychiatric Annals 20,439-445 (1990).
   Google Scholar
• Gammans RE, Westrick ML, Shea JP et al Pharmacokinetics of buspirone in elderly subjects. J. Clin. Pharmacol 29,72–78 (1989).
   PubMedGoogle Scholar
• Napoliello MJ. An interim multicentre report on 677 anxious geriatric out-patients treated with buspirone. BE j Clin. Pract. 40,71-73 (1986).
   Google Scholar
• Bohm C, Robinson DS, Gammans RE et al Buspirone therapy in anxious elderly patients: a controlled clinical trial.j Clin. Psychopharmacal 10\(Suppl. 3), 47S-51S (1990).
   Google Scholar
• Dada F, Sethi S, Grossberg GT. Generalized
   Google Scholar
• •anxiety disorder in the elder. Psychiatric Clin. N. Am. 24(1), 155–164 (2001).
   Google Scholar
• Robinson DS, Napoliello MJ, Schenk J. The safety and usefulness of buspirone as an anxiolytic drug in elderly versus young patients. Clin. Ther. 10,740–746 (1988).
   Google Scholar
• Schweizer E. Generalized anxiety disorder: longitudinal course and pharmacologic treatment. Psychiatr Clin. N. A117. 18,843-857 (1995).
   Google Scholar
• Young RC, Meyers BS. Psychopharmacology. In: Comprehensive Review of Geriatric Psychiatry — IL Sadavoy J, Lazarus LW Jarvik LF, Grossberg GT (Eds). American Psychiatric Press Inc., Washington DC, USA, 755–817 (1996).
   Google Scholar
• Cantillon M, Brunswick R, Molina D etal Buspirone vs. haloperidol: a double-blind trial for agitation in a nursing home population with Alzheimer's disease. Am j Geriatr Psychiatry 4,263–267 (1996).
   PubMedGoogle Scholar
• Levy MA. A trial of buspirone for the control of disruptive behaviors in community-dwelling patients with dementia. Int. J. Geriatric fiychiatry9, 841–848 (1994).
   Google Scholar
• Sakauye KM, Camp CJ, Ford PA. Effects of buspirone on agitation associated with dementia. Am. J. Geriatr Psych. 1,82–84 (1993).
   Google Scholar
• Herrmann N, Eryavec G. Buspirone in the management of agitation and aggression associated with dementia. Am. J. Geriatr Psych. 1,249–253 (1993).
   PubMedGoogle Scholar
• Colenda C. Buspirone in treatment of agitated demented patients. Lancet 21, 1169 (1988).
   Google Scholar
• Tiller JWG, Dakis JA, Shaw JM. Short- term buspirone treatment in disinhibition with dementia. Lancet 2 (8609), 510 (1988).
   PubMedGoogle Scholar
• Cooper JW, Cobb IIf I III, Burfield AH. Effects of psychotropic load reduction and buspirone conversion on behavioral disturbances in a nursing home population. Consult Pharm. 16,358–363 (2001).
   Google Scholar
• Cooper J. Consultant pharmacist assessment and reduction of fall risk in nursing facilities. Consult Pharmacist12, 1294–1304 (1997).
   Google Scholar
• Cooper J. Consultant pharmacist assessment of psychoactive fall injury incidence and costs within the nursing facility. Consult Pharm. 12,1305–1309 (1997).
   Google Scholar
• Lawlor BA, Radcliffe J, Molchan SE etal A pilot placebo-controlled study of trazodone and buspirone in Alzheimer's disease. int. J. Geriatr fiychiatry9, 55–59 (1994).
   Web of Science ®Google Scholar
• Stanislav SW, Fabre T, Crismon ML, Childs A. Buspirone's efficacy in organic-induced aggression. J. Clin. Psychopharmacol 14(2), 126–130 (1994).
   Google Scholar
• Batki SL. Buspirone in drug users with AIDS or AIDS-related complex. J. Clin. Psychopharmacol 10\(Suppl. 3), S111—S115 (1990).
   Google Scholar
• Ratey J, Sovner R, Parks A et al Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple baseline, placebo lead-in-study. J. Clin. Psychiatry52, 159–162 (1991).
   PubMed Web of Science ®Google Scholar
• Guay DRP, Lott A. Agitation/aggression in patients with dementia and developmental disability. Consult Pharm. 11,149–165 (1996).
   Google Scholar
• Herrmann N. Use of SSRIs in the elderly:
   Google Scholar
• •obvious benefits but unappreciated risks. Can.j Clin. Pharmacol 7(2), 91–95 (2000).
   Google Scholar
• Cooper JW. Falls and fractures in nursing home patients receiving psychotropic drugs. Int.j Geriatric PFhiatry9, 975–980 (1994).
   Google Scholar
• Street J, Clark WS, Gannon KS etal Olanzapine treatment of psychosis and behavioral disturbances in patients with Alzheimer's disease in nursing care facilities. Arch. Gen. PFchiatry57, 968–976 (2000).
   PubMed Web of Science ®Google Scholar
• Markovitz PJ. Treatment of anxiety in the
   Google Scholar
• •elderly. j Gun. Rychiatry54, 64–68 (1993).
   Google Scholar
• Sheikh JI, Salzman C. Anxiety in the
   Google Scholar
• •elderly. Course and treatment. Rychiatr Gun. N. A117. 18(4), 871–883 (1995).
   Google Scholar
• Rovner BW, German PS, Bwadhead J etal The prevalence and management of dementia and other psychiatric disorders in nursing homes. Int. Psychogeriatr 2,13–24 (1990).
   PubMedGoogle Scholar
• Mathews FE, Dening T Prevalence of dementia in institutional care. Lancet 360, 225–226 (2002).
   PubMed Web of Science ®Google Scholar
• Avorn J, Gurwitz JH. Drug use in the nursing home. Arch. Int. Med 123,195–204 (1995).
   Google Scholar
• Rakel RE. Long-term buspirone therapy for chronic anxiety: A multicenter international study to determine safety. South Med. 15,186–192 (1990).
   Google Scholar
• Lyketsos C, Olin J. Depression in Alzheimer's disease: overview and treatment. Biol. Psychiatry52(3), 243 (2002).
   PubMed Web of Science ®Google Scholar